World Pharma News
MAY 26, 2025
A widely used antidepressant drug could help the immune system fight cancer, according to a new UCLA research study. Selective serotonin reuptake inhibitors, or SSRIs, significantly enhanced the ability of T cells to fight cancer and suppressed tumor growth across a range of cancer types in both mouse and human tumor models, the study, published in Cell, found.
STAT
MAY 26, 2025
For the ailing gene editing industry, hope came earlier this month in the tiny, smiling, fuzzy-headed form of KJ Muldoon. At just 6 months old, KJ received a gene editing treatment custom-built to correct his unique mutation. He’s not cured, researchers explained at the annual American Society of Gene & Cell Therapy meeting in New Orleans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
MAY 26, 2025
Company secures regulatory approvals for commercial rollout in UK and US
Pharmaceutical Technology
MAY 26, 2025
The European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSKs Blenrep.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma Times
MAY 26, 2025
First non-immunosuppressive dual-action therapy approved for eligible patients
pharmaphorum
MAY 26, 2025
Jazz and PharmaMar have revealed the overall survival data with their small-cell lung cancer drug Zepzelca, described as a 'milestone' in the disease
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
MAY 26, 2025
A study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight
Express Pharma
MAY 26, 2025
Lupin announced that it has entered into a license and supply agreement with SteinCares, a specialty healthcare company in Latin America, for commercialisation of Lupins biosimilar ranibizumab across Latin America excluding Mexico and Argentina. Under the terms of the agreement, SteinCares will handle all regulatory filings, registrations and commercialisation of Ranibizumab in LATAM, while Lupin will be responsible for manufacturing the same.
Drug Patent Watch
MAY 26, 2025
"The Secret Sauce Behind Switzerland's Thriving Pharma Scene: It's Not Just About Chocolate and Mountains As the global pharma landscape continues to evolve, one country stands out for its remarkable success: Switzerland. With a market share of over 25% of the global pharmaceutical industry, the Swiss pharma sector is a powerhouse to be reckoned with.
Express Pharma
MAY 26, 2025
Quadria Capital, a healthcare-focused private equity firm, announced the final close of its Fund III with $1.07 billion in total commitments, significantly exceeding its original $800 million target. The oversubscribed fundraise comprises over $954 million in primary commitments and $114 million in committed co-investment capital. An additional $300 million co-investment capacity is anticipated over the course of the investment phase, bringing total committed capital to approximately $1.3 billio
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTech
MAY 26, 2025
Webinar Date/Time: Tue, Jun 17, 2025 11:00 AM EDT
pharmaphorum
MAY 26, 2025
Changing Faces Agency, consultancy, and investor hires April 2025 Nicole.
European Pharmaceutical Review
MAY 26, 2025
New clinical data suggest potential for the first targeted aldosterone synthase inhibitor to treat uncontrolled or resistant hypertension. Launch-HTN trial is the largest Phase III clinical trial of a novel drug for hypertension. The findings showed that lorundrostat enabled a sustained reduction in blood pressure across a large and diverse population of 1,083 adult patients.
pharmaphorum
MAY 26, 2025
We saw a range of hires in April in pharma-adjacent sectors like manufacturing and clinical research. Read on for the full update.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma and Life Sciences Blog
MAY 26, 2025
How a Top Retailer Took Control of Tariff-Linked Supplier Price Hikes priyanka.katke Mon, 05/26/2025 - 20:47 With a rush of supplier cost increase requests tied to tariffs and no way to validate them, a Fortune 100 U.S. retailer had to act fast. It partnered with GEP to build a centralized, SKU-level tool that reviews claims, recalculates tariff costs, and flags unsupported increases.
Pharmaceutical Technology
MAY 26, 2025
The EMA has validated the MAA submitted by Soleno Therapeutics for diazoxide choline prolonged-release tablets for Prader-Willi syndrome.
Pharmaceutical Business Review
MAY 26, 2025
This key plasma protein of Shilpa is utilised across different medical applications. It is developed using a non-human expression system that ensures scalability, high safety and virus-free production. This is aimed at addressing key limitations that are associated with albumin that are derived from humans. Shilpa is currently developing the product.
Pharmaceutical Commerce
MAY 26, 2025
In the final part of his Pharma Commerce video interview, Kevin Dondarski, Deloittes life sciences R&D strategy leader, describes best practices for balancing long-term pipeline sustainability with short-term financial returns.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology
MAY 26, 2025
The China NMPA's CDE has granted breakthrough therapy designation approval to Abbisko Therapeutics irpagratinib for HCC.
Pharmacy Times
MAY 26, 2025
Pharmacists improve outcomes by clarifying and delabeling inaccurate antibiotic allergies.
Welltopia Pharmacy
MAY 26, 2025
Doctors have many tools now to help manage RA, but its not perfect. That’s why some are considering adding new options to the mix, like combining LDN with RA therapies. Rheumatoid arthritis (RA) is a tough condition. People living with it face daily pain, swelling, and stiffness.
Pharmacy Times
MAY 26, 2025
The process teaches resilience, adaptability, and self-awareness.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
STAT
MAY 26, 2025
Harvard University has long stood on top of the academic world. Thousands from all over seek a coveted spot every year at the Ivy League school with a reputation for cultivating future leaders, from Nobel Prize recipients to high-ranking elected officials. But now, as the standoff between the university and the Trump administration escalates, the appeal of Harvard, and its standing on the global stage, seemingly hangs in the balance.
Pharmacy Times
MAY 26, 2025
RSV vaccines for pregnant women and infants require careful timing and administration.
FDA Law Blog: Biosimilars
MAY 26, 2025
By Andrew J. Hull & JP Ellison At our webinar earlier this month, we talked about Administration priorities as they relate to the FDC Act and noted that we expect much to remain the same with respect to enforcement. One notable exception has been the Administrations targeting of certain surgical procedures and the use of certain drugs for a particular intended purpose.
Pharmacy Times
MAY 26, 2025
The authors are optimistic that GADD45A serves as a foundation for therapeutic approaches to slow the progression of heart failure.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 26, 2025
These directives are typically used to shape federal agencies and manage employees in the executive branch.
Pharmacy Times
MAY 26, 2025
A panelist discusses key insights for pharmacists to prioritize, including staying informed about new respiratory syncytial virus (RSV) vaccines such as Arexvy and Abrysvo, educating patients on the benefits of vaccination, monitoring common adverse effects, ensuring timely access to vaccines, and playing a crucial role in supporting patient safety and prevention efforts for RSV.
Pharmacy Times
MAY 26, 2025
A panelist discusses recent advancements in the respiratory syncytial virus (RSV) vaccine space, including the approval of Arexvy and Abrysvo for older adults and pregnant individuals, the development of promising mRNA and protein subunit vaccines for high-risk groups, and ongoing studies to optimize dosing schedules and booster needs, all aimed at reducing RSV-related hospitalizations and deaths.
Expert insights. Personalized for you.
47 
Let's personalize your content